150 related articles for article (PubMed ID: 1997178)
1. Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice.
Singhal A; Fohn M; Hakomori S
Cancer Res; 1991 Mar; 51(5):1406-11. PubMed ID: 1997178
[TBL] [Abstract][Full Text] [Related]
2. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
O'Boyle KP; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd KO; Oettgen HF; Old LJ; Livingston PO
Cancer Res; 1992 Oct; 52(20):5663-7. PubMed ID: 1394190
[TBL] [Abstract][Full Text] [Related]
3. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
Fung PY; Longenecker BM
Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S
Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349
[TBL] [Abstract][Full Text] [Related]
6. Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn.
O'Boyle KP; Coatsworth S; Anthony G; Ramirez M; Greenwald E; Kaleya R; Steinberg JJ; Dutcher JP; Wiernik PH
Cancer Immun; 2006 Mar; 6():5. PubMed ID: 16524255
[TBL] [Abstract][Full Text] [Related]
7. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
Apostolopoulos V; Xing PX; McKenzie IF
Cancer Res; 1994 Oct; 54(19):5186-93. PubMed ID: 7923138
[TBL] [Abstract][Full Text] [Related]
8. Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin.
O'Boyle KP; Wright K
Hum Antibodies Hybridomas; 1994; 5(1-2):25-31. PubMed ID: 7532023
[TBL] [Abstract][Full Text] [Related]
9. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity.
Ogata S; Maimonis PJ; Itzkowitz SH
Cancer Res; 1992 Sep; 52(17):4741-6. PubMed ID: 1511439
[TBL] [Abstract][Full Text] [Related]
10. A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice.
Snyder LA; Goletz TJ; Gunn GR; Shi FF; Harris MC; Cochlin K; McCauley C; McCarthy SG; Branigan PJ; Knight DM
Vaccine; 2006 Apr; 24(16):3340-52. PubMed ID: 16472547
[TBL] [Abstract][Full Text] [Related]
11. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer.
Itzkowitz SH; Yuan M; Montgomery CK; Kjeldsen T; Takahashi HK; Bigbee WL; Kim YS
Cancer Res; 1989 Jan; 49(1):197-204. PubMed ID: 2908846
[TBL] [Abstract][Full Text] [Related]
12. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity.
Eck SC; Turka LA
Cancer Res; 2001 Apr; 61(7):3077-83. PubMed ID: 11306490
[TBL] [Abstract][Full Text] [Related]
14. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.
Galli-Stampino L; Meinjohanns E; Frische K; Meldal M; Jensen T; Werdelin O; Mouritsen S
Cancer Res; 1997 Aug; 57(15):3214-22. PubMed ID: 9242452
[TBL] [Abstract][Full Text] [Related]
15. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
[TBL] [Abstract][Full Text] [Related]
16. Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response.
Parajuli P; Pisarev V; Sublet J; Steffel A; Varney M; Singh R; LaFace D; Talmadge JE
Cancer Res; 2001 Nov; 61(22):8227-34. PubMed ID: 11719454
[TBL] [Abstract][Full Text] [Related]
17. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
Longenecker BM; Reddish M; Koganty R; MacLean GD
Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
[TBL] [Abstract][Full Text] [Related]
19. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant.
Longenecker BM; Reddish M; Koganty R; MacLean GD
Ann N Y Acad Sci; 1993 Aug; 690():276-91. PubMed ID: 7690215
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
